Nexalin Backing Senate Bill to Expand Medicare AI Device Reimbursement
Nexalin supports bipartisan Health Tech Investment Act to expand Medicare reimbursement for FDA-approved AI medical devices, aiding innovation in mental health treatment.
Nexalin supports bipartisan Health Tech Investment Act to expand Medicare reimbursement for FDA-approved AI medical devices, aiding innovation in mental health treatment.